Trial Profile
Manganese-Enhanced Magnetic Resonance Imaging: Applications in Cardiomyopathy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 May 2020
Price :
$35
*
At a glance
- Drugs Mangafodipir (Primary)
- Indications Cardiomyopathies; Dilated cardiomyopathy; Hypertrophic cardiomyopathy
- Focus Pharmacodynamics
- 06 Aug 2018 New trial record